Company: CYTK
Filing Date: 2025-02-27
Form Type: 8-K
Source: 0000950170-25-029017
Chunk: 0

Company: CYTOKINETICS INC
Filing Date: 2025-02-27
Form: 8-K
Item: Item 2.02
Chunk 0
---
Item 2.02 Results of Operations and Financial Condition.

On February 27, 2025, Cytokinetics, Incorporated announced its financial results for the fourth quarter and for the year ended December 31, 2024. The full text of the press release issued in connection with this announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information furnished under this Item 2.02 and under Exhibit 99.1 shall not be considered “filed” under the Securities Exchange Act of 1934, as amended, nor shall it be incorporated by reference into any future filing under the Securities Act of 1933, as amended, or under the Securities Exchange Act of 1934, as amended, unless the Registrant expressly sets forth in such future filing that such information is to be considered “filed” or incorporated by reference therein.

Item 9.01 Financial Statements and Exhibits.